CAM
CCXI
Cormorant Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,425,000
| Closed | -$35.3M | – | 84 |
|
|
2022
Q2 | $35.3M | Buy |
1,425,000
+560,000
| +65% | +$13.9M | 2.67% | 8 |
|
|
2022
Q1 | $21.7M | Buy |
865,000
+465,000
| +116% | +$11.7M | 1.67% | 18 |
|
|
2021
Q4 | $14.6M | Buy |
+400,000
| New | +$14.6M | 0.87% | 34 |
|
|
2021
Q2 | – | Sell |
-850,000
| Closed | -$43.6M | – | 130 |
|
|
2021
Q1 | $43.6M | Sell |
850,000
-350,000
| -29% | -$17.9M | 0.97% | 22 |
|
|
2020
Q4 | $74.3M | Sell |
1,200,000
-200,000
| -14% | -$12.4M | 1.77% | 15 |
|
|
2020
Q3 | $76.7M | Sell |
1,400,000
-300,000
| -18% | -$16.4M | 2.95% | 5 |
|
|
2020
Q2 | $97.8M | Sell |
1,700,000
-325,000
| -16% | -$18.7M | 3.73% | 3 |
|
|
2020
Q1 | $81.4M | Sell |
2,025,000
-875,000
| -30% | -$35.2M | 3.78% | 4 |
|
|
2019
Q4 | $115M | Buy |
2,900,000
+1,080,000
| +59% | +$42.7M | 4.58% | 4 |
|
|
2019
Q3 | $12.3M | Sell |
1,820,000
-545,280
| -23% | -$3.7M | 0.75% | 34 |
|
|
2019
Q2 | $22M | Sell |
2,365,280
-160,620
| -6% | -$1.49M | 1.26% | 24 |
|
|
2019
Q1 | $35.1M | Buy |
+2,525,900
| New | +$35.1M | 2.37% | 13 |
|